Crossmark

Measuring quality of life of primary antibody deficiency patients using a disease-specific health-related quality of life questionnaire for common variable immunodeficiency (CVID_QoL)

Crossref DOI link: https://doi.org/10.1186/s41687-019-0101-x

Published Online: 2019-02-26

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Andersen, Jintana B. https://orcid.org/0000-0002-4335-0700
Midttun, Knut

Feragen, Kristin J. B.
License Information

Text and Data Mining valid from 2019-02-26
More Information

Article History

Received: 26 November 2018

Accepted: 30 January 2019

First Online: 26 February 2019

Ethics approval and consent to participate

: Informed consent was obtained from all individual participants included in the study. The Data Protection Officer at Oslo University Hospital, Norway, gave their recommendation in processing health information for the study (#17/21472).

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Document is current

Any future updates will be listed below